Professor Abdool Karim’s keynote speech provided an overview of the current COVID-19 situation in South Africa, including updates and suggestions for tackling the pandemic. In addition, Professor Abdool Karim discussed how we can ensure the continuation of non-COVID-19 clinical trials and advancing drug development.
To watch this webinar, click here
Professor Salim S. Abdool Karim, FRS
Salim S. Abdool Karim, FRS, is a South African clinical infectious diseases epidemiologist who is widely recognized for his scientific contributions to HIV prevention and treatment. He is Director of the Centre for the AIDS Program of Research in South Africa (CAPRISA) and CAPRISA Professor of Global Health in Epidemiology at Columbia University. He is also Pro Vice-Chancellor (Research) at the University of KwaZulu-Natal, South Africa and Associate Member of The Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT) and Harvard University. He has adjunct professorships at Cornell and Harvard universities. He has served as the President of the South African Medical Research Council and is currently serving as the Chair of the South African Ministerial Advisory Committee on COVID-19.
Dr Abdool Karim is ranked among the World’s most cited scientists by Web of Science. He serves on the Boards of several journals, including the New England Journal of Medicine, Lancet Global Health, Lancet HIV and mBio. He is the Chair of the UNAIDS Scientific Expert Panel, WHO’s HIV Strategic and Technical Advisory Committee as well as the WHO TB-HIV Task Force and is a member of the Scientific Advisory Board for Global Health at the Bill and Melinda Gates Foundation.
His many awards include the African Union’s “Kwame Nkrumah Award”, the most prestigious scientific award in Africa and the Canadian Gairdner Award. He is a Fellow of the Royal Society and member of the US National Academy of Medicine, the American Academy of Microbiology and the Association of American Physicians.